Crispr Therapeutics shares tumble after significant earnings miss
Chief Operating Officer Tan Kwang Hooi of Flex Ltd (NASDAQ:FLEX), a $18.85 billion electronic equipment manufacturer trading near its 52-week high after delivering a 58.72% return over the past year, sold 12,500 ordinary shares of the company on July 28, 2025. The shares were sold at a weighted average price of $50.2482, with individual sales prices ranging from $49.92 to $50.68, totaling $628,102. According to InvestingPro analysis, the stock currently trades at a P/E ratio of 21.69 and appears slightly overvalued relative to its Fair Value estimate.
Following the transaction, Tan Kwang Hooi directly owns 263,636 Flex Ltd. shares, which includes unvested restricted share units. 23,981 of these will vest in two equal annual installments beginning on June 12, 2026; 21,964 will vest in three equal annual installments beginning on June 12, 2026; 16,195 will vest on June 14, 2026; and 72,578 will vest on September 25, 2027.
This sale was executed under a pre-arranged Rule 10b5-1 trading plan.
In other recent news, Flex Ltd reported a strong performance for its first fiscal quarter of 2026, with adjusted earnings per share reaching $0.72, surpassing the analyst forecast of $0.63. The company’s revenue also exceeded expectations, coming in at $6.6 billion compared to the projected $6.26 billion. Despite these positive financial results, Flex Ltd’s stock experienced a decline in pre-market trading. Additionally, the company raised its revenue guidance to $26.5 billion from the previously anticipated $25.9 billion. KeyBanc Capital Markets maintained its Overweight rating on Flextronics, viewing the recent 7.7% stock sell-off as a buying opportunity. KeyBanc attributed the stock drop to investor concerns over the maintained operating margin guidance of 6.0-6.1%, despite the higher revenue outlook. These developments highlight recent investor reactions and analyst perspectives regarding Flex Ltd’s financial performance and future expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.